umlaut_journal_tocs 0.0.1

Sign up to get free protection for your applications and to get access to all the features.
Files changed (62) hide show
  1. checksums.yaml +7 -0
  2. data/MIT-LICENSE +20 -0
  3. data/Rakefile +37 -0
  4. data/app/item_decorators/umlaut_journal_tocs_decorator.rb +50 -0
  5. data/app/service_adaptors/journal_tocs_adapter.rb +51 -0
  6. data/app/views/umlaut_journal_tocs/_bento_item.html.erb +80 -0
  7. data/app/views/umlaut_journal_tocs/_resolve_section.html.erb +10 -0
  8. data/config/locales/en.yml +5 -0
  9. data/config/routes.rb +2 -0
  10. data/lib/tasks/umlaut_journal_tocs_tasks.rake +4 -0
  11. data/lib/umlaut_journal_tocs.rb +26 -0
  12. data/lib/umlaut_journal_tocs/engine.rb +18 -0
  13. data/lib/umlaut_journal_tocs/version.rb +3 -0
  14. data/test/controller_test.rb +36 -0
  15. data/test/dummy/README.rdoc +28 -0
  16. data/test/dummy/Rakefile +6 -0
  17. data/test/dummy/app/assets/javascripts/application.js +17 -0
  18. data/test/dummy/app/assets/stylesheets/application.css +19 -0
  19. data/test/dummy/app/controllers/application_controller.rb +5 -0
  20. data/test/dummy/app/controllers/umlaut_controller.rb +136 -0
  21. data/test/dummy/app/helpers/application_helper.rb +2 -0
  22. data/test/dummy/app/views/layouts/application.html.erb +14 -0
  23. data/test/dummy/bin/bundle +3 -0
  24. data/test/dummy/bin/rails +4 -0
  25. data/test/dummy/bin/rake +4 -0
  26. data/test/dummy/bin/setup +29 -0
  27. data/test/dummy/config.ru +4 -0
  28. data/test/dummy/config/application.rb +26 -0
  29. data/test/dummy/config/boot.rb +5 -0
  30. data/test/dummy/config/database.yml +60 -0
  31. data/test/dummy/config/environment.rb +5 -0
  32. data/test/dummy/config/environments/development.rb +45 -0
  33. data/test/dummy/config/environments/production.rb +83 -0
  34. data/test/dummy/config/environments/test.rb +42 -0
  35. data/test/dummy/config/initializers/assets.rb +11 -0
  36. data/test/dummy/config/initializers/backtrace_silencers.rb +7 -0
  37. data/test/dummy/config/initializers/cookies_serializer.rb +3 -0
  38. data/test/dummy/config/initializers/filter_parameter_logging.rb +4 -0
  39. data/test/dummy/config/initializers/inflections.rb +16 -0
  40. data/test/dummy/config/initializers/mime_types.rb +4 -0
  41. data/test/dummy/config/initializers/session_store.rb +3 -0
  42. data/test/dummy/config/initializers/umlaut_journal_tocs.rb +20 -0
  43. data/test/dummy/config/initializers/wrap_parameters.rb +14 -0
  44. data/test/dummy/config/locales/en.yml +23 -0
  45. data/test/dummy/config/routes.rb +57 -0
  46. data/test/dummy/config/secrets.yml +22 -0
  47. data/test/dummy/config/umlaut_services.yml +23 -0
  48. data/test/dummy/db/migrate/20150901192508_umlaut_init.umlaut.rb +106 -0
  49. data/test/dummy/db/migrate/20150901192509_umlaut_add_service_response_index.umlaut.rb +10 -0
  50. data/test/dummy/db/schema.rb +118 -0
  51. data/test/dummy/public/404.html +67 -0
  52. data/test/dummy/public/422.html +67 -0
  53. data/test/dummy/public/500.html +66 -0
  54. data/test/dummy/public/favicon.ico +0 -0
  55. data/test/journal_tocs_adapter_test.rb +93 -0
  56. data/test/support/vcr_filter.rb +45 -0
  57. data/test/test_helper.rb +39 -0
  58. data/test/vcr_cassettes/generates_no_response.yml +49 -0
  59. data/test/vcr_cassettes/generates_response.yml +952 -0
  60. data/test/vcr_cassettes/gets_results.yml +804 -0
  61. data/test/vcr_cassettes/registers_proper_error.yml +40 -0
  62. metadata +200 -0
@@ -0,0 +1,67 @@
1
+ <!DOCTYPE html>
2
+ <html>
3
+ <head>
4
+ <title>The page you were looking for doesn't exist (404)</title>
5
+ <meta name="viewport" content="width=device-width,initial-scale=1">
6
+ <style>
7
+ body {
8
+ background-color: #EFEFEF;
9
+ color: #2E2F30;
10
+ text-align: center;
11
+ font-family: arial, sans-serif;
12
+ margin: 0;
13
+ }
14
+
15
+ div.dialog {
16
+ width: 95%;
17
+ max-width: 33em;
18
+ margin: 4em auto 0;
19
+ }
20
+
21
+ div.dialog > div {
22
+ border: 1px solid #CCC;
23
+ border-right-color: #999;
24
+ border-left-color: #999;
25
+ border-bottom-color: #BBB;
26
+ border-top: #B00100 solid 4px;
27
+ border-top-left-radius: 9px;
28
+ border-top-right-radius: 9px;
29
+ background-color: white;
30
+ padding: 7px 12% 0;
31
+ box-shadow: 0 3px 8px rgba(50, 50, 50, 0.17);
32
+ }
33
+
34
+ h1 {
35
+ font-size: 100%;
36
+ color: #730E15;
37
+ line-height: 1.5em;
38
+ }
39
+
40
+ div.dialog > p {
41
+ margin: 0 0 1em;
42
+ padding: 1em;
43
+ background-color: #F7F7F7;
44
+ border: 1px solid #CCC;
45
+ border-right-color: #999;
46
+ border-left-color: #999;
47
+ border-bottom-color: #999;
48
+ border-bottom-left-radius: 4px;
49
+ border-bottom-right-radius: 4px;
50
+ border-top-color: #DADADA;
51
+ color: #666;
52
+ box-shadow: 0 3px 8px rgba(50, 50, 50, 0.17);
53
+ }
54
+ </style>
55
+ </head>
56
+
57
+ <body>
58
+ <!-- This file lives in public/404.html -->
59
+ <div class="dialog">
60
+ <div>
61
+ <h1>The page you were looking for doesn't exist.</h1>
62
+ <p>You may have mistyped the address or the page may have moved.</p>
63
+ </div>
64
+ <p>If you are the application owner check the logs for more information.</p>
65
+ </div>
66
+ </body>
67
+ </html>
@@ -0,0 +1,67 @@
1
+ <!DOCTYPE html>
2
+ <html>
3
+ <head>
4
+ <title>The change you wanted was rejected (422)</title>
5
+ <meta name="viewport" content="width=device-width,initial-scale=1">
6
+ <style>
7
+ body {
8
+ background-color: #EFEFEF;
9
+ color: #2E2F30;
10
+ text-align: center;
11
+ font-family: arial, sans-serif;
12
+ margin: 0;
13
+ }
14
+
15
+ div.dialog {
16
+ width: 95%;
17
+ max-width: 33em;
18
+ margin: 4em auto 0;
19
+ }
20
+
21
+ div.dialog > div {
22
+ border: 1px solid #CCC;
23
+ border-right-color: #999;
24
+ border-left-color: #999;
25
+ border-bottom-color: #BBB;
26
+ border-top: #B00100 solid 4px;
27
+ border-top-left-radius: 9px;
28
+ border-top-right-radius: 9px;
29
+ background-color: white;
30
+ padding: 7px 12% 0;
31
+ box-shadow: 0 3px 8px rgba(50, 50, 50, 0.17);
32
+ }
33
+
34
+ h1 {
35
+ font-size: 100%;
36
+ color: #730E15;
37
+ line-height: 1.5em;
38
+ }
39
+
40
+ div.dialog > p {
41
+ margin: 0 0 1em;
42
+ padding: 1em;
43
+ background-color: #F7F7F7;
44
+ border: 1px solid #CCC;
45
+ border-right-color: #999;
46
+ border-left-color: #999;
47
+ border-bottom-color: #999;
48
+ border-bottom-left-radius: 4px;
49
+ border-bottom-right-radius: 4px;
50
+ border-top-color: #DADADA;
51
+ color: #666;
52
+ box-shadow: 0 3px 8px rgba(50, 50, 50, 0.17);
53
+ }
54
+ </style>
55
+ </head>
56
+
57
+ <body>
58
+ <!-- This file lives in public/422.html -->
59
+ <div class="dialog">
60
+ <div>
61
+ <h1>The change you wanted was rejected.</h1>
62
+ <p>Maybe you tried to change something you didn't have access to.</p>
63
+ </div>
64
+ <p>If you are the application owner check the logs for more information.</p>
65
+ </div>
66
+ </body>
67
+ </html>
@@ -0,0 +1,66 @@
1
+ <!DOCTYPE html>
2
+ <html>
3
+ <head>
4
+ <title>We're sorry, but something went wrong (500)</title>
5
+ <meta name="viewport" content="width=device-width,initial-scale=1">
6
+ <style>
7
+ body {
8
+ background-color: #EFEFEF;
9
+ color: #2E2F30;
10
+ text-align: center;
11
+ font-family: arial, sans-serif;
12
+ margin: 0;
13
+ }
14
+
15
+ div.dialog {
16
+ width: 95%;
17
+ max-width: 33em;
18
+ margin: 4em auto 0;
19
+ }
20
+
21
+ div.dialog > div {
22
+ border: 1px solid #CCC;
23
+ border-right-color: #999;
24
+ border-left-color: #999;
25
+ border-bottom-color: #BBB;
26
+ border-top: #B00100 solid 4px;
27
+ border-top-left-radius: 9px;
28
+ border-top-right-radius: 9px;
29
+ background-color: white;
30
+ padding: 7px 12% 0;
31
+ box-shadow: 0 3px 8px rgba(50, 50, 50, 0.17);
32
+ }
33
+
34
+ h1 {
35
+ font-size: 100%;
36
+ color: #730E15;
37
+ line-height: 1.5em;
38
+ }
39
+
40
+ div.dialog > p {
41
+ margin: 0 0 1em;
42
+ padding: 1em;
43
+ background-color: #F7F7F7;
44
+ border: 1px solid #CCC;
45
+ border-right-color: #999;
46
+ border-left-color: #999;
47
+ border-bottom-color: #999;
48
+ border-bottom-left-radius: 4px;
49
+ border-bottom-right-radius: 4px;
50
+ border-top-color: #DADADA;
51
+ color: #666;
52
+ box-shadow: 0 3px 8px rgba(50, 50, 50, 0.17);
53
+ }
54
+ </style>
55
+ </head>
56
+
57
+ <body>
58
+ <!-- This file lives in public/500.html -->
59
+ <div class="dialog">
60
+ <div>
61
+ <h1>We're sorry, but something went wrong.</h1>
62
+ </div>
63
+ <p>If you are the application owner check the logs for more information.</p>
64
+ </div>
65
+ </body>
66
+ </html>
File without changes
@@ -0,0 +1,93 @@
1
+ require 'test_helper'
2
+
3
+ class JournalTocsAdapterTest < ActiveSupport::TestCase
4
+ extend TestWithCassette
5
+
6
+ before do
7
+ @service_config = {
8
+ "type" => "JournalTocsAdapter",
9
+ "priority" => 1
10
+ }
11
+ @service_config_list = {'default' => {
12
+ "services" => {
13
+ "journal_tocs" => @service_config
14
+ }
15
+ }
16
+ }
17
+
18
+ @service = JournalTocsAdapter.new(@service_config.merge("service_id" => "journal_tocs"))
19
+ end
20
+
21
+ describe "with no ISSN" do
22
+ test "does nothing" do
23
+ umlaut_request = fake_umlaut_request("/resolve?jtitle=Journal+Of+Something&genre=journal")
24
+
25
+ @service.handle(umlaut_request)
26
+
27
+ assert_dispatched umlaut_request, "journal_tocs"
28
+ assert_service_responses umlaut_request, 'journal_tocs', :number => 0
29
+ end
30
+ end
31
+
32
+ describe "article-level citation" do
33
+ test "does nothing" do
34
+ @umlaut_request = fake_umlaut_request("/resolve?jtitle=JAMA&genre=article&issn=1538-3598&volume=1&issue=1&spage=1")
35
+ @service.handle(@umlaut_request)
36
+
37
+ assert_dispatched @umlaut_request, "journal_tocs"
38
+ response = assert_service_responses @umlaut_request, 'journal_tocs', :number => 0
39
+ end
40
+ end
41
+
42
+ describe "with ISSN that works" do
43
+ before do
44
+ @umlaut_request = fake_umlaut_request("/resolve?au=JAMA&genre=journal&issn=1538-3598")
45
+ end
46
+
47
+ test_with_cassette "generates response" do
48
+ @service.handle(@umlaut_request)
49
+
50
+ assert_dispatched @umlaut_request, "journal_tocs"
51
+ response = assert_service_responses @umlaut_request, 'journal_tocs', :number => 1
52
+
53
+ # Can we de-serialize?
54
+ bento_results = BentoSearch::Results.load_json(response.service_data)
55
+
56
+ assert_kind_of BentoSearch::Results, bento_results
57
+ assert bento_results.count > 0
58
+ bento_results.each do |result|
59
+ assert_kind_of BentoSearch::ResultItem, result
60
+ end
61
+ end
62
+ end
63
+
64
+ describe "with ISSN with no JournalTocs results" do
65
+ before do
66
+ @umlaut_request = fake_umlaut_request("/resolve?au=JAMA&genre=journal&issn=12345678")
67
+ end
68
+
69
+ test_with_cassette("generates no response") do
70
+ @service.handle(@umlaut_request)
71
+
72
+ assert_dispatched @umlaut_request, "journal_tocs"
73
+ assert_service_responses @umlaut_request, 'journal_tocs', :number => 0
74
+ end
75
+ end
76
+
77
+ describe "with bad email" do
78
+ before do
79
+ config = @service_config.merge("service_id" => "journal_tocs",
80
+ "bento_search_engine" => "bad_email_journal_tocs")
81
+ @service = JournalTocsAdapter.new(config)
82
+
83
+ @umlaut_request = fake_umlaut_request("/resolve?au=JAMA&genre=journal&issn=12345678")
84
+ end
85
+ test_with_cassette "registers proper error" do
86
+ @service.handle(@umlaut_request)
87
+
88
+ assert_dispatched @umlaut_request, "journal_tocs", "failed_temporary"
89
+ assert_service_responses @umlaut_request, 'journal_tocs', :number => 0
90
+ end
91
+ end
92
+
93
+ end
@@ -0,0 +1,45 @@
1
+ require 'vcr'
2
+
3
+ # Convenience for using VCR's filter_sensitive_data according to our common
4
+ # pattern.
5
+ #
6
+ # For a sensitive piece of information, set in your shell environment variable eg:
7
+ #
8
+ # BD_FINDITEM_PATRON="patron_barcode"
9
+ #
10
+ # Then call in a test:
11
+ # VCRFilter.sensitive_data! :bd_finditem_patron
12
+ #
13
+ # In the tests, when you need to use the piece of data somewhere, use
14
+ # VCRFilter[:bd_library_symbol]
15
+ #
16
+ # eg
17
+ # BorrowDirect::FindItem.new(VCRFilter[:bd_finditem_patron])
18
+ #
19
+ # Optional but recommended, use VCR cassette tags...
20
+ # VCRFilter.sensitive_data!, :bd_finditem_patron, :bd_finditem_tests
21
+ # #...
22
+ # describe "BD finditem items", :vcr => {:tag => :bd_finditem_tests}
23
+ #
24
+ # When recording a new cassette, the value from ENV will be used in interactions
25
+ # with remote service, but won't be saved in your on disk cassettes -- it will
26
+ # be saved as eg DUMMY_BD_FINDITEM_PATRON instead.
27
+ #
28
+ # When running from recorded cassettes, you don't need to have the ENV defined, but
29
+ # when (re-)recording a cassette, you of course do.
30
+ module VCRFilter
31
+ @@data = {}
32
+ def self.[](key) ; @@data[key.to_s.downcase] ; end
33
+ def self.[]=(key, value) ; @@data[key.to_s.downcase] = value ; end
34
+
35
+ def self.sensitive_data!(key, vcr_tag = nil)
36
+ env_key = key.to_s.upcase
37
+ dummy_value = "DUMMY_#{env_key}"
38
+
39
+ self[key] = (ENV[env_key] || dummy_value)
40
+
41
+ VCR.configure do |c|
42
+ c.filter_sensitive_data( dummy_value, vcr_tag ) { self[key] }
43
+ end
44
+ end
45
+ end
@@ -0,0 +1,39 @@
1
+ # Configure Rails Environment
2
+ ENV["RAILS_ENV"] = "test"
3
+
4
+ require File.expand_path("../../test/dummy/config/environment.rb", __FILE__)
5
+ ActiveRecord::Migrator.migrations_paths = [File.expand_path("../../test/dummy/db/migrate", __FILE__)]
6
+ require "rails/test_help"
7
+
8
+ require 'minitest-spec-rails'
9
+
10
+ require 'umlaut'
11
+ require 'umlaut/test_help'
12
+ include Umlaut::TestHelp
13
+
14
+ # Filter out Minitest backtrace while allowing backtrace from other libraries
15
+ # to be shown.
16
+ Minitest.backtrace_filter = Minitest::BacktraceFilter.new
17
+
18
+ # Load support files
19
+ Dir["#{File.dirname(__FILE__)}/support/**/*.rb"].each do |f|
20
+ require f
21
+ end
22
+
23
+
24
+
25
+ # Load fixtures from the engine
26
+ if ActiveSupport::TestCase.respond_to?(:fixture_path=)
27
+ ActiveSupport::TestCase.fixture_path = File.expand_path("../fixtures", __FILE__)
28
+ ActiveSupport::TestCase.fixtures :all
29
+ end
30
+
31
+ if defined?(VCR)
32
+ VCR.configure do |c|
33
+ c.cassette_library_dir = 'test/vcr_cassettes'
34
+ c.hook_into :webmock # or :fakeweb
35
+ end
36
+ end
37
+
38
+ VCRFilter.sensitive_data! :journal_tocs_email
39
+
@@ -0,0 +1,49 @@
1
+ ---
2
+ http_interactions:
3
+ - request:
4
+ method: get
5
+ uri: http://www.journaltocs.ac.uk/api/journals/12345678?output=articles&user=DUMMY_JOURNAL_TOCS_EMAIL
6
+ body:
7
+ encoding: UTF-8
8
+ string: ''
9
+ headers:
10
+ User-Agent:
11
+ - HTTPClient/1.0 (2.6.0.1, ruby 2.2.2 (2015-04-13))
12
+ Accept:
13
+ - "*/*"
14
+ Date:
15
+ - Thu, 03 Sep 2015 20:09:21 GMT
16
+ response:
17
+ status:
18
+ code: 200
19
+ message: OK
20
+ headers:
21
+ Date:
22
+ - Thu, 03 Sep 2015 20:09:21 GMT
23
+ Server:
24
+ - Apache
25
+ X-Powered-By:
26
+ - PHP/5.3.3
27
+ Content-Length:
28
+ - '1192'
29
+ Content-Type:
30
+ - application/xml; charset=utf-8
31
+ body:
32
+ encoding: UTF-8
33
+ string: "<?xml version=\"1.0\" encoding=\"utf-8\"?>\n<rdf:RDF xmlns:rdf=\"http://www.w3.org/1999/02/22-rdf-syntax-ns#\"\r\n
34
+ \ xmlns=\"http://purl.org/rss/1.0/\"\r\n xmlns:mn=\"http://usefulinc.com/rss/manifest/\"\r\n
35
+ \ xmlns:dc=\"http://purl.org/dc/elements/1.1/\">\n\n <channel rdf:about=\"http://www.journaltocs.hw.ac.uk/api/journals\">\r\n
36
+ \ <title>JournalTOCs API - Found 0 journals for: 12345678 (0 articles)</title>\r\n
37
+ \ <link>http://www.journaltocs.ac.uk/api/journals/12345678</link>\r\n <description><![CDATA[Your
38
+ query: 12345678 has returned 0 articles. Table of contents is currently unavailable
39
+ for this journal. Please report to S.Chumbe@hw.ac.uk]]></description>\r\n
40
+ \ <dc:publisher>JournalTOCs API</dc:publisher>\r\n <dc:creator>JOURNALTOCS
41
+ API PROJECT</dc:creator>\r\n\t\t<dc:coverage>0</dc:coverage>\r\n <image
42
+ rdf:resource=\"http://www.journaltocs.ac.uk/images/jtocslogo.gif\" />\r\n
43
+ \ <items>\r\n <rdf:Seq>\r\n </rdf:Seq>\r\n </items>\r\n </channel>\r\n
44
+ \ \r\n\t\r\n <rdf:Description rdf:ID=\"manifest\">\r\n <mn:channels>\r\n
45
+ \ <rdf:Seq>\r\n <rdf:li rdf:resource=\"http://www.journaltocs.hw.ac.uk/api/journals\"
46
+ />\r\n </rdf:Seq>\r\n </mn:channels>\r\n </rdf:Description>\r\n\r\n</rdf:RDF>"
47
+ http_version:
48
+ recorded_at: Thu, 03 Sep 2015 20:09:21 GMT
49
+ recorded_with: VCR 2.9.3
@@ -0,0 +1,952 @@
1
+ ---
2
+ http_interactions:
3
+ - request:
4
+ method: get
5
+ uri: http://www.journaltocs.ac.uk/api/journals/15383598?output=articles&user=DUMMY_JOURNAL_TOCS_EMAIL
6
+ body:
7
+ encoding: UTF-8
8
+ string: ''
9
+ headers:
10
+ User-Agent:
11
+ - HTTPClient/1.0 (2.6.0.1, ruby 2.2.2 (2015-04-13))
12
+ Accept:
13
+ - "*/*"
14
+ Date:
15
+ - Thu, 03 Sep 2015 20:09:19 GMT
16
+ response:
17
+ status:
18
+ code: 200
19
+ message: OK
20
+ headers:
21
+ Date:
22
+ - Thu, 03 Sep 2015 20:09:20 GMT
23
+ Server:
24
+ - Apache
25
+ X-Powered-By:
26
+ - PHP/5.3.3
27
+ Transfer-Encoding:
28
+ - chunked
29
+ Content-Type:
30
+ - application/xml; charset=utf-8
31
+ body:
32
+ encoding: UTF-8
33
+ string: "<?xml version=\"1.0\" encoding=\"UTF-8\"?>\n<rdf:RDF xmlns:rdf=\"http://www.w3.org/1999/02/22-rdf-syntax-ns#\"
34
+ \r\n xmlns:prism=\"http://prismstandard.org/namespaces/1.2/basic/\"
35
+ \r\n\t\t\t\t xmlns:dc=\"http://purl.org/dc/elements/1.1/\" \r\n\t\t\t\t xmlns:mn=\"http://usefulinc.com/rss/manifest/\"\r\n\t\t\t\t
36
+ xmlns:content=\"http://purl.org/rss/1.0/modules/content/\" \r\n\t\t\t\t xmlns=\"http://purl.org/rss/1.0/\">\n\n
37
+ \ <channel rdf:about=\"http://www.journaltocs.hw.ac.uk/api/journals\">\r\n
38
+ \ <title>JournalTOCs API - JAMA The Journal of the American Medical Association
39
+ (38 articles)</title>\r\n <link>http://www.journaltocs.ac.uk/api/journals/15383598</link>\r\n
40
+ \ <description><![CDATA[Your query: 15383598 has returned 38 articles. They
41
+ are listed in alphabetical order per journal (maximum number of returned items
42
+ is 3000).]]></description>\r\n <dc:publisher>JournalTOCs API</dc:publisher>\r\n
43
+ \ <dc:creator>JOURNALTOCS API PROJECT</dc:creator>\r\n\t\t<dc:coverage>1</dc:coverage>\r\n
44
+ \ <image rdf:resource=\"http://www.journaltocs.ac.uk/images/jtocslogo.gif\"
45
+ />\r\n <items>\r\n <rdf:Seq><rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429716\"
46
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429719\"
47
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429717\"
48
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429702\"
49
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429693\"
50
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429712\"
51
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429698\"
52
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429725\"
53
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429724\"
54
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429688\"
55
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429709\"
56
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429699\"
57
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429700\"
58
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429695\"
59
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429691\"
60
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2424669\"
61
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429711\"
62
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429710\"
63
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429694\"
64
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429706\"
65
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429705\"
66
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429707\"
67
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429690\"
68
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429689\"
69
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429713\"
70
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429714\"
71
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429715\"
72
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429696\"
73
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429697\"
74
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429692\"
75
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429703\"
76
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429704\"
77
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429701\"
78
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2338495\"
79
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429723\"
80
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2319350\"
81
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2338303\"
82
+ />\n<rdf:li rdf:resource=\"http://jama.jamanetwork.com/article.aspx?articleID=2429718\"
83
+ />\n\r\n </rdf:Seq>\r\n </items>\r\n </channel>\r\n <item rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429716\">\n<title>Childhood
84
+ Obesity</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429716</link>\r\n<description>&lt;span
85
+ class=\"paragraphSection\"&gt;&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429716</dc:identifier>\r\n<dc:creator>Thompson
86
+ AE.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
87
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
88
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
89
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429716\"><b>Childhood
90
+ Obesity</b></A><br />Thompson AE. <br /><i>JAMA The Journal of the American
91
+ Medical Association, Vol. , No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
92
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429719\">\n<title>JAMA</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429719</link>\r\n<description>&lt;br&gt;\nArticle
93
+ URL: http://jama.jamanetwork.com/article.aspx?articleID=2429719&lt;br&gt;\nCitation:
94
+ \ (2015) &lt;br&gt;\nPublication Date: Tue, 25 Aug 2015 00:00:00 GMT&lt;br&gt;\nJournal:
95
+ JAMA The Journal of the American Medical Association</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429719</dc:identifier>\r\n<dc:publisher>American
96
+ Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
97
+ of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
98
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
99
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429719\"><b>JAMA</b></A><br
100
+ /> <br /><i>JAMA The Journal of the American Medical Association, Vol. , No.
101
+ \ (2015) pp. - </i><br />\nArticle URL: http://jama.jamanetwork.com/article.aspx?articleID=2429719\nCitation:
102
+ \ (2015) \nPublication Date: Tue, 25 Aug 2015 00:00:00 GMT\nJournal: JAMA
103
+ The Journal of the American Medical Association</p>]]></content:encoded>\r\n</item>\n<item
104
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429717\">\n<title>Knowing</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429717</link>\r\n<description>&lt;span
105
+ class=\"paragraphSection\"&gt;Streaks of blue above the treetopsand brightening
106
+ white cloudsbeneath the heavier still windless graysin this tilt to longer
107
+ light already under waytogether with a shift of knowingstirred as endless
108
+ colorin this window patch of sky.And in my lungs a space of knowing named
109
+ at last,which like the changed sky, forever changing,subtle as the light of
110
+ so much more to know remaining.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429717</dc:identifier>\r\n<dc:creator>Halberstadt
111
+ C.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
112
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
113
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
114
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429717\"><b>Knowing</b></A><br
115
+ />Halberstadt C. <br /><i>JAMA The Journal of the American Medical Association,
116
+ Vol. , No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;Streaks
117
+ of blue above the treetopsand brightening white cloudsbeneath the heavier
118
+ still windless graysin this tilt to longer light already under waytogether
119
+ with a shift of knowingstirred as endless colorin this window patch of sky.And
120
+ in my lungs a space of knowing named at last,which like the changed sky, forever
121
+ changing,subtle as the light of so much more to know remaining.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
122
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429702\">\n<title>The
123
+ House: Its Unique Problems in Hygiene</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429702</link>\r\n<description>&lt;span
124
+ class=\"paragraphSection\"&gt;A house erected in accord with modern science
125
+ and the builder&#8217;s art must satisfy a few apparently simple needs. These
126
+ have been cleverly summarized in the following words: protection from the
127
+ elements, from cold and heat, from rain and snow and damp, from intruders
128
+ who might interfere with the family safety or possessions; water at hand;
129
+ some way of getting rid of waste; space for the family, for all their occupations
130
+ and belongings; room for a guest: these were sought by even the cave dwellers.
131
+ And we have not passed beyond these simple needs. Our enemies are of a different
132
+ kind, but the daily paper shows that we must pay for safety locks; and while
133
+ wild animals no longer prowl about, we find it almost impossible to keep out
134
+ rats and mice and harmful insects. The &#8220;house&#8221; fly is now called
135
+ a &#8220;typhoid&#8221; fly, and not permitted even as a casual visitor. To
136
+ all these needs we have added what the cave man did not seek for, since his
137
+ life was largely out of doors. We must have air and sun within doors. Doctors
138
+ are now talking about house diseases. Tuberculosis is one of these, and the
139
+ fight against it must be made, in part, just here. It is for sun and air that
140
+ we have to pay large rents in town; and it is partly to secure these in our
141
+ large dwellings that tenement-house commissions exist, to protect those who
142
+ cannot protect themselves. Then, too, there must be protection against fire,
143
+ not only by the fire department but also in the house itself. Modern nerves,
144
+ moreover, demand quiet. We may want our own phonograph, but we do not care
145
+ to hear our neighbor&#8217;s, and walls and floors must be built to keep out
146
+ sounds. We call these simple needs. They would seem to be human rights; but
147
+ even now, in this twentieth century, how many houses rank 100 per cent. in
148
+ all these: in warmth and coolness at proper seasons; perfect dryness, ventilation
149
+ and lighting; safety from fire and intruders; and room for each member of
150
+ the family to be by himself, and to keep an open door to guests&#39; Yet,
151
+ we cannot be as well or as happy or as useful as we should, until these are
152
+ achieved.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429702</dc:identifier>\r\n<dc:publisher>American
153
+ Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
154
+ of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
155
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
156
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429702\"><b>The
157
+ House: Its Unique Problems in Hygiene</b></A><br /> <br /><i>JAMA The Journal
158
+ of the American Medical Association, Vol. , No. (2015) pp. - </i><br />&lt;span
159
+ class=\"paragraphSection\"&gt;A house erected in accord with modern science
160
+ and the builder&#8217;s art must satisfy a few apparently simple needs. These
161
+ have been cleverly summarized in the following words: protection from the
162
+ elements, from cold and heat, from rain and snow and damp, from intruders
163
+ who might interfere with the family safety or possessions; water at hand;
164
+ some way of getting rid of waste; space for the family, for all their occupations
165
+ and belongings; room for a guest: these were sought by even the cave dwellers.
166
+ And we have not passed beyond these simple needs. Our enemies are of a different
167
+ kind, but the daily paper shows that we must pay for safety locks; and while
168
+ wild animals no longer prowl about, we find it almost impossible to keep out
169
+ rats and mice and harmful insects. The &#8220;house&#8221; fly is now called
170
+ a &#8220;typhoid&#8221; fly, and not permitted even as a casual visitor. To
171
+ all these needs we have added what the cave man did not seek for, since his
172
+ life was largely out of doors. We must have air and sun within doors. Doctors
173
+ are now talking about house diseases. Tuberculosis is one of these, and the
174
+ fight against it must be made, in part, just here. It is for sun and air that
175
+ we have to pay large rents in town; and it is partly to secure these in our
176
+ large dwellings that tenement-house commissions exist, to protect those who
177
+ cannot protect themselves. Then, too, there must be protection against fire,
178
+ not only by the fire department but also in the house itself. Modern nerves,
179
+ moreover, demand quiet. We may want our own phonograph, but we do not care
180
+ to hear our neighbor&#8217;s, and walls and floors must be built to keep out
181
+ sounds. We call these simple needs. They would seem to be human rights; but
182
+ even now, in this twentieth century, how many houses rank 100 per cent. in
183
+ all these: in warmth and coolness at proper seasons; perfect dryness, ventilation
184
+ and lighting; safety from fire and intruders; and room for each member of
185
+ the family to be by himself, and to keep an open door to guests&#39; Yet,
186
+ we cannot be as well or as happy or as useful as we should, until these are
187
+ achieved.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429693\">\n<title>Next-Generation
188
+ Sequencing to Detect Minimal Residual Disease in AML</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429693</link>\r\n<description>&lt;span
189
+ class=\"paragraphSection\"&gt;Acute myeloid leukemia (AML) represents a heterogeneous
190
+ disease, both with respect to molecular pathogenesis and clinical outcome.
191
+ Although dose-intensive chemotherapy and allogeneic stem cell transplantation
192
+ have improved outcomes in AML, there remains significant heterogeneity in
193
+ clinical outcome such that approximately 20% of patients are cured with existing
194
+ therapies, 20% have therapy-refractory disease from the time of diagnosis,
195
+ and 50% relapse and die from refractory disease after an initial response
196
+ to leukemia therapy. The challenge is how to best determine prognosis and
197
+ identify which patients will have a substantive chance of cure, and which
198
+ patients will likely relapse or present with refractory disease. Current standard
199
+ of care uses clinical, cytogenetic, and molecular factors for risk stratification;
200
+ however, there remains a pressing need for better approaches to prognostication
201
+ in AML.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429693</dc:identifier>\r\n<dc:creator>Pastore
202
+ F</dc:creator>\n<dc:creator>Levine RL.</dc:creator>\n<dc:publisher>American
203
+ Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
204
+ of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
205
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
206
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429693\"><b>Next-Generation
207
+ Sequencing to Detect Minimal Residual Disease in AML</b></A><br />Pastore
208
+ F Levine RL.<br /><i>JAMA The Journal of the American Medical Association,
209
+ Vol. , No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;Acute
210
+ myeloid leukemia (AML) represents a heterogeneous disease, both with respect
211
+ to molecular pathogenesis and clinical outcome. Although dose-intensive chemotherapy
212
+ and allogeneic stem cell transplantation have improved outcomes in AML, there
213
+ remains significant heterogeneity in clinical outcome such that approximately
214
+ 20% of patients are cured with existing therapies, 20% have therapy-refractory
215
+ disease from the time of diagnosis, and 50% relapse and die from refractory
216
+ disease after an initial response to leukemia therapy. The challenge is how
217
+ to best determine prognosis and identify which patients will have a substantive
218
+ chance of cure, and which patients will likely relapse or present with refractory
219
+ disease. Current standard of care uses clinical, cytogenetic, and molecular
220
+ factors for risk stratification; however, there remains a pressing need for
221
+ better approaches to prognostication in AML.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
222
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429712\">\n<title>Activity
223
+ Intervention vs Health Education in Sedentary Older Adults</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429712</link>\r\n<description>&lt;span
224
+ class=\"paragraphSection\"&gt;This randomized trial assessed the effects of
225
+ a 24-month physical activity program on cognitive function, mild cognitive
226
+ impairment, and dementia compared with a health education program in sedentary
227
+ adults aged 70 to 89 years.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429712</dc:identifier>\r\n<dc:creator>Sink
228
+ KM</dc:creator>\n<dc:creator>Espeland MA</dc:creator>\n<dc:creator>Castro
229
+ CM</dc:creator>\n<dc:creator>et al.</dc:creator>\n<dc:publisher>American Medical
230
+ Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal of the
231
+ American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
232
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
233
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429712\"><b>Activity
234
+ Intervention vs Health Education in Sedentary Older Adults</b></A><br />Sink
235
+ KM Espeland MA, Castro CM, et al.<br /><i>JAMA The Journal of the American
236
+ Medical Association, Vol. , No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;This
237
+ randomized trial assessed the effects of a 24-month physical activity program
238
+ on cognitive function, mild cognitive impairment, and dementia compared with
239
+ a health education program in sedentary adults aged 70 to 89 years.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
240
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429698\">\n<title>Recommendations
241
+ to Improve Cardiac Arrest Survival</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429698</link>\r\n<description>&lt;span
242
+ class=\"paragraphSection\"&gt;About 600&#8239;000 people in the United States
243
+ experience cardiac arrest each year, and the National Academy of Medicine
244
+ (NAM) recently released a report titled &#8220;Strategies to Improve Cardiac
245
+ Arrest Survival: A Time to Act&#8221; that details cardiac arrest outcomes
246
+ in the United States and provides recommendations for increasing cardiac arrest
247
+ survival rates (&lt;a href=\"http://bit.ly/1HSyLOQ\"&gt;http://bit.ly/1HSyLOQ&lt;/a&gt;).
248
+ The NAM convened a committee of experts to conduct the study, sponsored by
249
+ the American Heart Association, American Red Cross, American College of Cardiology,
250
+ Centers for Disease Control and Prevention, National Institutes of Health,
251
+ and US Department of Veterans Affairs. According to the report, current survival
252
+ rates are less than 6% for individuals who experience cardiac arrest outside
253
+ of the hospital and less than 24% for patients who experience cardiac arrest
254
+ while hospitalized.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429698</dc:identifier>\r\n<dc:creator>Jacob
255
+ JA.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
256
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
257
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
258
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429698\"><b>Recommendations
259
+ to Improve Cardiac Arrest Survival</b></A><br />Jacob JA. <br /><i>JAMA The
260
+ Journal of the American Medical Association, Vol. , No. (2015) pp. - </i><br
261
+ />&lt;span class=\"paragraphSection\"&gt;About 600&#8239;000 people in the
262
+ United States experience cardiac arrest each year, and the National Academy
263
+ of Medicine (NAM) recently released a report titled &#8220;Strategies to Improve
264
+ Cardiac Arrest Survival: A Time to Act&#8221; that details cardiac arrest
265
+ outcomes in the United States and provides recommendations for increasing
266
+ cardiac arrest survival rates (&lt;a href=\"http://bit.ly/1HSyLOQ\"&gt;http://bit.ly/1HSyLOQ&lt;/a&gt;).
267
+ The NAM convened a committee of experts to conduct the study, sponsored by
268
+ the American Heart Association, American Red Cross, American College of Cardiology,
269
+ Centers for Disease Control and Prevention, National Institutes of Health,
270
+ and US Department of Veterans Affairs. According to the report, current survival
271
+ rates are less than 6% for individuals who experience cardiac arrest outside
272
+ of the hospital and less than 24% for patients who experience cardiac arrest
273
+ while hospitalized.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
274
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429725\">\n<title>Health
275
+ Advice Needed to Cut US Sodium Intake</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429725</link>\r\n<description>&lt;span
276
+ class=\"paragraphSection\"&gt;About half of nearly 200&#8239;000 US adults
277
+ reported in a recent survey that they&#8217;re watching their salt intake
278
+ or reducing it, but only 1 in 5 said a health professional advised them to
279
+ cut back. The data are from the 2013 Behavioral Risk Factor Surveillance System
280
+ telephone survey, which for the first time has provided state-level estimates
281
+ of sodium intake among the general population.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429725</dc:identifier>\r\n<dc:publisher>American
282
+ Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
283
+ of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
284
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
285
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429725\"><b>Health
286
+ Advice Needed to Cut US Sodium Intake</b></A><br /> <br /><i>JAMA The Journal
287
+ of the American Medical Association, Vol. , No. (2015) pp. - </i><br />&lt;span
288
+ class=\"paragraphSection\"&gt;About half of nearly 200&#8239;000 US adults
289
+ reported in a recent survey that they&#8217;re watching their salt intake
290
+ or reducing it, but only 1 in 5 said a health professional advised them to
291
+ cut back. The data are from the 2013 Behavioral Risk Factor Surveillance System
292
+ telephone survey, which for the first time has provided state-level estimates
293
+ of sodium intake among the general population.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
294
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429724\">\n<title>Rapid
295
+ US Response to Ebola Threat</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429724</link>\r\n<description>&lt;span
296
+ class=\"paragraphSection\"&gt;More than 10&#8239;000 US residents were monitored
297
+ for potential Ebola virus exposure from November 2014 to March 2015 after
298
+ the CDC issued guidance on preventing transmission of the virus in the United
299
+ States, according to a recent report.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429724</dc:identifier>\r\n<dc:publisher>American
300
+ Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
301
+ of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
302
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
303
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429724\"><b>Rapid
304
+ US Response to Ebola Threat</b></A><br /> <br /><i>JAMA The Journal of the
305
+ American Medical Association, Vol. , No. (2015) pp. - </i><br />&lt;span
306
+ class=\"paragraphSection\"&gt;More than 10&#8239;000 US residents were monitored
307
+ for potential Ebola virus exposure from November 2014 to March 2015 after
308
+ the CDC issued guidance on preventing transmission of the virus in the United
309
+ States, according to a recent report.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
310
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429688\">\n<title>Mahabalipooram</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429688</link>\r\n<description>&lt;span
311
+ class=\"paragraphSection\"&gt;The extraordinary life of Edward Lear (1812-1888)
312
+ seems to continue in spirit across space and time from Victorian England to
313
+ the present-day world, conveyed in his captivating works. It may be amusing
314
+ to consider that the same person who concocted the whimsical poem &#8220;The
315
+ Owl and the Pussy-cat&#8221; also gave art lessons to the Queen. Ornithological
316
+ illustrations were included in his early oeuvre, with his later work featuring
317
+ landscapes emanating the allure of faraway lands. &lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429688</dc:identifier>\r\n<dc:creator>Smith
318
+ JM.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
319
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
320
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
321
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429688\"><b>Mahabalipooram</b></A><br
322
+ />Smith JM. <br /><i>JAMA The Journal of the American Medical Association,
323
+ Vol. , No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;The
324
+ extraordinary life of Edward Lear (1812-1888) seems to continue in spirit
325
+ across space and time from Victorian England to the present-day world, conveyed
326
+ in his captivating works. It may be amusing to consider that the same person
327
+ who concocted the whimsical poem &#8220;The Owl and the Pussy-cat&#8221; also
328
+ gave art lessons to the Queen. Ornithological illustrations were included
329
+ in his early oeuvre, with his later work featuring landscapes emanating the
330
+ allure of faraway lands. &lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
331
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429709\">\n<title>Diabetes
332
+ Remission After Bariatric Surgery</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429709</link>\r\n<description>&lt;span
333
+ class=\"paragraphSection\"&gt;Obese individuals with type 2 diabetes mellitus
334
+ experienced a remission of their diabetes after bariatric surgery followed
335
+ by 2 years of lifestyle weight loss intervention, according to a recent randomized
336
+ clinical trial. Those who had 3 years of lifestyle modification alone&#8212;1
337
+ year of intensive weight loss counseling followed by 2 years of twice-monthly
338
+ sessions focused on weight loss strategies&#8212;saw no remission of their
339
+ diabetes. The study provided important data on the surgical treatment of individuals
340
+ with class I obesity (body mass index of 30 to &lt;35), who have previously
341
+ been excluded from bariatric surgical trials. The trial also assessed type
342
+ 2 diabetes remission among individuals who received laparoscopic adjustable
343
+ gastric banding (LABG), a reversible and low-risk procedure that may be a
344
+ better surgical alternative for those with lower body mass index (Courcoulas
345
+ AP et al. &lt;span style=\"font-style:italic;\"&gt;JAMA Surg&lt;/span&gt;.
346
+ doi:&lt;a href=\"http://jamanetwork.com/article.aspx&#39;doi=10.1001/jamasurg.2015.1534\"&gt;10.1001/jamasurg.2015.1534&lt;/a&gt;
347
+ [published online July 1, 2015]).&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429709</dc:identifier>\r\n<dc:creator>Slomski
348
+ A.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
349
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
350
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
351
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429709\"><b>Diabetes
352
+ Remission After Bariatric Surgery</b></A><br />Slomski A. <br /><i>JAMA The
353
+ Journal of the American Medical Association, Vol. , No. (2015) pp. - </i><br
354
+ />&lt;span class=\"paragraphSection\"&gt;Obese individuals with type 2 diabetes
355
+ mellitus experienced a remission of their diabetes after bariatric surgery
356
+ followed by 2 years of lifestyle weight loss intervention, according to a
357
+ recent randomized clinical trial. Those who had 3 years of lifestyle modification
358
+ alone&#8212;1 year of intensive weight loss counseling followed by 2 years
359
+ of twice-monthly sessions focused on weight loss strategies&#8212;saw no remission
360
+ of their diabetes. The study provided important data on the surgical treatment
361
+ of individuals with class I obesity (body mass index of 30 to &lt;35), who
362
+ have previously been excluded from bariatric surgical trials. The trial also
363
+ assessed type 2 diabetes remission among individuals who received laparoscopic
364
+ adjustable gastric banding (LABG), a reversible and low-risk procedure that
365
+ may be a better surgical alternative for those with lower body mass index
366
+ (Courcoulas AP et al. &lt;span style=\"font-style:italic;\"&gt;JAMA Surg&lt;/span&gt;.
367
+ doi:&lt;a href=\"http://jamanetwork.com/article.aspx&#39;doi=10.1001/jamasurg.2015.1534\"&gt;10.1001/jamasurg.2015.1534&lt;/a&gt;
368
+ [published online July 1, 2015]).&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
369
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429699\">\n<title>CMS
370
+ Proposes Payment for Advance Care Planning Discussions</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429699</link>\r\n<description>&lt;span
371
+ class=\"paragraphSection\"&gt;The Centers for Medicare &amp; Medicaid Services
372
+ (CMS) is seeking comment on a proposal to add separate payment rates and codes
373
+ for advance care planning conversations between Medicare beneficiaries and
374
+ physicians or other health care professionals paid under the Medicare Physician
375
+ Fee Schedule. Such discussions may cover, for example, information on treatment
376
+ options, advance directives, and forms patients need to complete to express
377
+ their wishes for end-of-life care. The proposal to offer paid benefit for
378
+ an initial 30-minute session on advance care planning and additional discussions
379
+ would &#8220;better enable seniors and other Medicare beneficiaries to make
380
+ important decisions that give them control over the type of care they receive
381
+ and when they receive it,&#8221; stated a CMS fact sheet (&lt;a href=\"http://go.cms.gov/1KR7miD\"&gt;http://go.cms.gov/1KR7miD&lt;/a&gt;).&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429699</dc:identifier>\r\n<dc:creator>Jacob
382
+ JA.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
383
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
384
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
385
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429699\"><b>CMS
386
+ Proposes Payment for Advance Care Planning Discussions</b></A><br />Jacob
387
+ JA. <br /><i>JAMA The Journal of the American Medical Association, Vol. ,
388
+ No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;The Centers
389
+ for Medicare &amp; Medicaid Services (CMS) is seeking comment on a proposal
390
+ to add separate payment rates and codes for advance care planning conversations
391
+ between Medicare beneficiaries and physicians or other health care professionals
392
+ paid under the Medicare Physician Fee Schedule. Such discussions may cover,
393
+ for example, information on treatment options, advance directives, and forms
394
+ patients need to complete to express their wishes for end-of-life care. The
395
+ proposal to offer paid benefit for an initial 30-minute session on advance
396
+ care planning and additional discussions would &#8220;better enable seniors
397
+ and other Medicare beneficiaries to make important decisions that give them
398
+ control over the type of care they receive and when they receive it,&#8221;
399
+ stated a CMS fact sheet (&lt;a href=\"http://go.cms.gov/1KR7miD\"&gt;http://go.cms.gov/1KR7miD&lt;/a&gt;).&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
400
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429700\">\n<title>HHS
401
+ Establishes Training and Education Center for Ebola</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429700</link>\r\n<description>&lt;span
402
+ class=\"paragraphSection\"&gt;The Department of Health and Human Service (HHS)
403
+ has allocated $12 million in funds over the next 5 years for a new National
404
+ Ebola Training and Education Center (&lt;a href=\"http://1.usa.gov/1dxrLug\"&gt;http://1.usa.gov/1dxrLug&lt;/a&gt;).
405
+ The Center&#8217;s co-leaders&#8212;Emory University in Atlanta, University
406
+ of Nebraska Medical Center in Omaha, and Bellevue Hospital Center in New York
407
+ City&#8212;will receive the funding to develop and teach courses in caring
408
+ for patients with Ebola and other serious infectious diseases based on evidence-based
409
+ best practices. The training will be offered to state health departments and
410
+ health care facilities.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429700</dc:identifier>\r\n<dc:creator>Jacob
411
+ JA.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
412
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
413
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
414
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429700\"><b>HHS
415
+ Establishes Training and Education Center for Ebola</b></A><br />Jacob JA.
416
+ <br /><i>JAMA The Journal of the American Medical Association, Vol. , No.
417
+ \ (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;The Department
418
+ of Health and Human Service (HHS) has allocated $12 million in funds over
419
+ the next 5 years for a new National Ebola Training and Education Center (&lt;a
420
+ href=\"http://1.usa.gov/1dxrLug\"&gt;http://1.usa.gov/1dxrLug&lt;/a&gt;).
421
+ The Center&#8217;s co-leaders&#8212;Emory University in Atlanta, University
422
+ of Nebraska Medical Center in Omaha, and Bellevue Hospital Center in New York
423
+ City&#8212;will receive the funding to develop and teach courses in caring
424
+ for patients with Ebola and other serious infectious diseases based on evidence-based
425
+ best practices. The training will be offered to state health departments and
426
+ health care facilities.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
427
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429695\">\n<title>Pediatric
428
+ Pulseless Arrest With &#8220;Nonshockable&#8221; Rhythm</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429695</link>\r\n<description>&lt;span
429
+ class=\"paragraphSection\"&gt;In this issue of &lt;span style=\"font-style:italic;\"&gt;JAMA&lt;/span&gt;,
430
+ Andersen et al report findings from their observational study based on data
431
+ from a national registry of 15&#8239;959 pediatric (&lt;18 years) in-hospital
432
+ cardiac arrests from 2000 to 2014, which included 1558 children (9.8%) who
433
+ received at least 1 dose of epinephrine for nonshockable rhythms (ie, pulseless
434
+ electrical activity or asystole) during cardiopulmonary resuscitation (CPR).
435
+ Among these children (median age, 9 months), 50% received epinephrine during
436
+ the same whole minute as the patient lost their pulse or the next whole minute;
437
+ only 15% received the first dose of epinephrine after 5 minutes of CPR. In
438
+ children receiving epinephrine for nonshockable rhythms, the authors found
439
+ that each minute of delay in epinephrine administration was associated with
440
+ adverse outcomes (ie, lower risk of return of spontaneous circulation [ROSC],
441
+ survival at 24 hours, and discharge from hospital with favorable outcome).&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429695</dc:identifier>\r\n<dc:creator>Tasker
442
+ RC</dc:creator>\n<dc:creator>Randolph AG.</dc:creator>\n<dc:publisher>American
443
+ Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
444
+ of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
445
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
446
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429695\"><b>Pediatric
447
+ Pulseless Arrest With &#8220;Nonshockable&#8221; Rhythm</b></A><br />Tasker
448
+ RC Randolph AG.<br /><i>JAMA The Journal of the American Medical Association,
449
+ Vol. , No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;In
450
+ this issue of &lt;span style=\"font-style:italic;\"&gt;JAMA&lt;/span&gt;,
451
+ Andersen et al report findings from their observational study based on data
452
+ from a national registry of 15&#8239;959 pediatric (&lt;18 years) in-hospital
453
+ cardiac arrests from 2000 to 2014, which included 1558 children (9.8%) who
454
+ received at least 1 dose of epinephrine for nonshockable rhythms (ie, pulseless
455
+ electrical activity or asystole) during cardiopulmonary resuscitation (CPR).
456
+ Among these children (median age, 9 months), 50% received epinephrine during
457
+ the same whole minute as the patient lost their pulse or the next whole minute;
458
+ only 15% received the first dose of epinephrine after 5 minutes of CPR. In
459
+ children receiving epinephrine for nonshockable rhythms, the authors found
460
+ that each minute of delay in epinephrine administration was associated with
461
+ adverse outcomes (ie, lower risk of return of spontaneous circulation [ROSC],
462
+ survival at 24 hours, and discharge from hospital with favorable outcome).&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
463
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429691\">\n<title>Lines
464
+ Omitted From Table</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429691</link>\r\n<description>&lt;span
465
+ class=\"paragraphSection\"&gt;In the Original Investigation entitled &#8220;Mortality,
466
+ Hospitalizations, and Expenditures for the Medicare Population Aged 65 Years
467
+ or Older, 1999-2013&#8221; published in the July 28, 2015, issue of &lt;span
468
+ style=\"font-style:italic;\"&gt;JAMA&lt;/span&gt;, the last 2 rows of Table
469
+ 2 (Expired and Others for 2007-2013) were inadvertently omitted. This article
470
+ was corrected online.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429691</dc:identifier>\r\n<dc:publisher>American
471
+ Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
472
+ of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
473
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
474
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429691\"><b>Lines
475
+ Omitted From Table</b></A><br /> <br /><i>JAMA The Journal of the American
476
+ Medical Association, Vol. , No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;In
477
+ the Original Investigation entitled &#8220;Mortality, Hospitalizations, and
478
+ Expenditures for the Medicare Population Aged 65 Years or Older, 1999-2013&#8221;
479
+ published in the July 28, 2015, issue of &lt;span style=\"font-style:italic;\"&gt;JAMA&lt;/span&gt;,
480
+ the last 2 rows of Table 2 (Expired and Others for 2007-2013) were inadvertently
481
+ omitted. This article was corrected online.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
482
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2424669\">\n<title>Safety
483
+ and Fairness in the Right-to-Try</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2424669</link>\r\n<description>&lt;span
484
+ class=\"paragraphSection\"&gt;This Medical News and Perspectives article discusses
485
+ issues surrounding Right-to-Try laws that allow patients with terminal illness
486
+ to petition for access to investigational drugs and therapies.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2424669</dc:identifier>\r\n<dc:creator>Jacob
487
+ JA.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
488
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
489
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
490
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2424669\"><b>Safety
491
+ and Fairness in the Right-to-Try</b></A><br />Jacob JA. <br /><i>JAMA The
492
+ Journal of the American Medical Association, Vol. , No. (2015) pp. - </i><br
493
+ />&lt;span class=\"paragraphSection\"&gt;This Medical News and Perspectives
494
+ article discusses issues surrounding Right-to-Try laws that allow patients
495
+ with terminal illness to petition for access to investigational drugs and
496
+ therapies.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429711\">\n<title>Bridging
497
+ Anticoagulation Offers No Benefit</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429711</link>\r\n<description>&lt;span
498
+ class=\"paragraphSection\"&gt;A recent trial found that among patients with
499
+ atrial fibrillation (AF) who stopped taking warfarin before undergoing an
500
+ elective surgery or invasive procedure, forgoing bridging anticoagulation
501
+ was noninferior to perioperative bridging with low-molecular-weight heparin
502
+ to prevent arterial thromboembolism. Bridging also nearly tripled the risk
503
+ of major bleeding without providing benefit in preventing myocardial infarction,
504
+ venous thromboembolism, or death when compared with no bridging (Douketis
505
+ JD et al. &lt;span style=\"font-style:italic;\"&gt;N Engl J Med&lt;/span&gt;.
506
+ doi:&lt;a href=\"http://dx.doi.org/10.1056/NEJMoa1501035\"&gt;10.1056/NEJMoa1501035&lt;/a&gt;
507
+ [published online June 22, 2015]).&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429711</dc:identifier>\r\n<dc:creator>Slomski
508
+ A.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
509
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
510
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
511
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429711\"><b>Bridging
512
+ Anticoagulation Offers No Benefit</b></A><br />Slomski A. <br /><i>JAMA The
513
+ Journal of the American Medical Association, Vol. , No. (2015) pp. - </i><br
514
+ />&lt;span class=\"paragraphSection\"&gt;A recent trial found that among patients
515
+ with atrial fibrillation (AF) who stopped taking warfarin before undergoing
516
+ an elective surgery or invasive procedure, forgoing bridging anticoagulation
517
+ was noninferior to perioperative bridging with low-molecular-weight heparin
518
+ to prevent arterial thromboembolism. Bridging also nearly tripled the risk
519
+ of major bleeding without providing benefit in preventing myocardial infarction,
520
+ venous thromboembolism, or death when compared with no bridging (Douketis
521
+ JD et al. &lt;span style=\"font-style:italic;\"&gt;N Engl J Med&lt;/span&gt;.
522
+ doi:&lt;a href=\"http://dx.doi.org/10.1056/NEJMoa1501035\"&gt;10.1056/NEJMoa1501035&lt;/a&gt;
523
+ [published online June 22, 2015]).&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
524
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429710\">\n<title>Diabetes
525
+ Drug Promotes Weight Loss in Patients</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429710</link>\r\n<description>&lt;span
526
+ class=\"paragraphSection\"&gt;Results from a recent placebo-controlled trial
527
+ suggest liraglutide, a glucagon-like peptide-1 analogue approved to treat
528
+ type 2 diabetes, can help shed body weight and improve glycemic control among
529
+ people who were very overweight or obese&#8212;but not diabetic. The trial,
530
+ consisting of 3731 participants, also found that participants who had taken
531
+ liraglutide had a significantly lower incidence of prediabetes after 56 weeks
532
+ and developed type 2 diabetes at a significantly lower rate compared with
533
+ participants taking placebo (Pi-Sunyer X et al. &lt;span style=\"font-style:italic;\"&gt;N
534
+ Engl J Med&lt;/span&gt;. 2015;373[1]:11-22).&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429710</dc:identifier>\r\n<dc:creator>Slomski
535
+ A.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
536
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
537
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
538
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429710\"><b>Diabetes
539
+ Drug Promotes Weight Loss in Patients</b></A><br />Slomski A. <br /><i>JAMA
540
+ The Journal of the American Medical Association, Vol. , No. (2015) pp. -
541
+ </i><br />&lt;span class=\"paragraphSection\"&gt;Results from a recent placebo-controlled
542
+ trial suggest liraglutide, a glucagon-like peptide-1 analogue approved to
543
+ treat type 2 diabetes, can help shed body weight and improve glycemic control
544
+ among people who were very overweight or obese&#8212;but not diabetic. The
545
+ trial, consisting of 3731 participants, also found that participants who had
546
+ taken liraglutide had a significantly lower incidence of prediabetes after
547
+ 56 weeks and developed type 2 diabetes at a significantly lower rate compared
548
+ with participants taking placebo (Pi-Sunyer X et al. &lt;span style=\"font-style:italic;\"&gt;N
549
+ Engl J Med&lt;/span&gt;. 2015;373[1]:11-22).&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
550
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429694\">\n<title>Optimizing
551
+ Cognitive Health in Older Individuals</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429694</link>\r\n<description>&lt;span
552
+ class=\"paragraphSection\"&gt;Loss of cognitive function and the development
553
+ of dementia are among the greatest concerns confronting older individuals.
554
+ As populations around the world age, the global prevalence of dementia is
555
+ predicted to increase substantially from an estimated 35.6 million in 2010
556
+ to 65.7 million in 2030, and 115.4 million in 2050. In the United States in
557
+ 1990, Alzheimer disease ranked 25th in terms of disability-adjusted life-years
558
+ lost. In 2010, it ranked 12th, with the greatest median percentage change
559
+ of any of the leading 30 diseases. The burden of mild cognitive impairment
560
+ (MCI) is even larger. Discussions between physicians and patients about strategies
561
+ to prevent cognitive decline and dementia have become commonplace, and there
562
+ is great interest in new evidence of lifestyle modifications that might improve
563
+ cognitive aging and prevent the onset of dementia. These lifestyle modifications
564
+ include exercise, dietary changes, cognitive training (ie, &#8220;brain games&#8221;),
565
+ and multimodal treatments. A meta-analysis of observational studies found
566
+ that the modifiable risk factors that have most consistently been associated
567
+ with a reduced risk of dementia include higher educational attainment, increased
568
+ physical activity, and avoidance of smoking.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429694</dc:identifier>\r\n<dc:creator>Gill
569
+ SS</dc:creator>\n<dc:creator>Seitz DP.</dc:creator>\n<dc:publisher>American
570
+ Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
571
+ of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
572
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
573
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429694\"><b>Optimizing
574
+ Cognitive Health in Older Individuals</b></A><br />Gill SS Seitz DP.<br /><i>JAMA
575
+ The Journal of the American Medical Association, Vol. , No. (2015) pp. -
576
+ </i><br />&lt;span class=\"paragraphSection\"&gt;Loss of cognitive function
577
+ and the development of dementia are among the greatest concerns confronting
578
+ older individuals. As populations around the world age, the global prevalence
579
+ of dementia is predicted to increase substantially from an estimated 35.6
580
+ million in 2010 to 65.7 million in 2030, and 115.4 million in 2050. In the
581
+ United States in 1990, Alzheimer disease ranked 25th in terms of disability-adjusted
582
+ life-years lost. In 2010, it ranked 12th, with the greatest median percentage
583
+ change of any of the leading 30 diseases. The burden of mild cognitive impairment
584
+ (MCI) is even larger. Discussions between physicians and patients about strategies
585
+ to prevent cognitive decline and dementia have become commonplace, and there
586
+ is great interest in new evidence of lifestyle modifications that might improve
587
+ cognitive aging and prevent the onset of dementia. These lifestyle modifications
588
+ include exercise, dietary changes, cognitive training (ie, &#8220;brain games&#8221;),
589
+ and multimodal treatments. A meta-analysis of observational studies found
590
+ that the modifiable risk factors that have most consistently been associated
591
+ with a reduced risk of dementia include higher educational attainment, increased
592
+ physical activity, and avoidance of smoking.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
593
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429706\">\n<title>Opioid
594
+ Dependence Treatment in the Emergency Department</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429706</link>\r\n<description>&lt;span
595
+ class=\"paragraphSection\"&gt;&lt;strong&gt;In Reply&lt;/strong&gt; Dr Swartz
596
+ provides an opportunity to discuss the fundamental principles of clinical
597
+ research and opioid dependence treatment that guided our study. Clinical trial
598
+ design involves selecting a primary, clinically important outcome at a point
599
+ in time. Our primary outcome was engagement in treatment at 30 days. We chose
600
+ engagement in treatment as the primary outcome because it is associated with
601
+ decreased criminal activity, HIV transmission, and mortality.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429706</dc:identifier>\r\n<dc:creator>Fiellin
602
+ DA</dc:creator>\n<dc:creator>O&amp;#8217;Connor PG, D&amp;#8217;Onofrio G.</dc:creator>\n<dc:publisher>American
603
+ Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
604
+ of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
605
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
606
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429706\"><b>Opioid
607
+ Dependence Treatment in the Emergency Department</b></A><br />Fiellin DA O&#8217;Connor
608
+ PG, D&#8217;Onofrio G.<br /><i>JAMA The Journal of the American Medical Association,
609
+ Vol. , No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;&lt;strong&gt;In
610
+ Reply&lt;/strong&gt; Dr Swartz provides an opportunity to discuss the fundamental
611
+ principles of clinical research and opioid dependence treatment that guided
612
+ our study. Clinical trial design involves selecting a primary, clinically
613
+ important outcome at a point in time. Our primary outcome was engagement in
614
+ treatment at 30 days. We chose engagement in treatment as the primary outcome
615
+ because it is associated with decreased criminal activity, HIV transmission,
616
+ and mortality.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429705\">\n<title>Etiologies
617
+ of Tattoo Lesions</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429705</link>\r\n<description>&lt;span
618
+ class=\"paragraphSection\"&gt;&lt;strong&gt;To the Editor&lt;/strong&gt; Dr
619
+ Ayoola and colleagues described a patient with systemic sarcoidosis presenting
620
+ with skin lesions of his tattoos. The authors stated that the differential
621
+ diagnosis of the skin lesions included drug eruptions, T-cell lymphoma, and
622
+ tuberculosis. However, other possibilities should have been considered.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429705</dc:identifier>\r\n<dc:creator>Han
623
+ F.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
624
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
625
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
626
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429705\"><b>Etiologies
627
+ of Tattoo Lesions</b></A><br />Han F. <br /><i>JAMA The Journal of the American
628
+ Medical Association, Vol. , No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;&lt;strong&gt;To
629
+ the Editor&lt;/strong&gt; Dr Ayoola and colleagues described a patient with
630
+ systemic sarcoidosis presenting with skin lesions of his tattoos. The authors
631
+ stated that the differential diagnosis of the skin lesions included drug eruptions,
632
+ T-cell lymphoma, and tuberculosis. However, other possibilities should have
633
+ been considered.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429707\">\n<title>Etiologies
634
+ of Tattoo Lesions</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429707</link>\r\n<description>&lt;span
635
+ class=\"paragraphSection\"&gt;&lt;strong&gt;In Reply&lt;/strong&gt; Mr Han
636
+ raises questions about the differential diagnosis of cutaneous manifestations
637
+ of sarcoidosis in tattoos. We included drug eruptions, T-cell lymphoma, and
638
+ tuberculosis as differential diagnoses for our patient with tattoo sarcoidosis.
639
+ One of the most common differential diagnoses is foreign body granuloma. These
640
+ reactions are attributable to the pigment in tattoo ink. Histologically they
641
+ can be differentiated by the presence of foreign bodies. Generally, reactions
642
+ to single pigments are found in foreign body granulomas; if multiple pigments
643
+ are involved, systemic sarcoidosis is more likely.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429707</dc:identifier>\r\n<dc:creator>Jamindar
644
+ P</dc:creator>\n<dc:creator>Powner J</dc:creator>\n<dc:creator>Ayoola R.</dc:creator>\n<dc:publisher>American
645
+ Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
646
+ of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
647
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
648
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429707\"><b>Etiologies
649
+ of Tattoo Lesions</b></A><br />Jamindar P Powner J, Ayoola R.<br /><i>JAMA
650
+ The Journal of the American Medical Association, Vol. , No. (2015) pp. -
651
+ </i><br />&lt;span class=\"paragraphSection\"&gt;&lt;strong&gt;In Reply&lt;/strong&gt;
652
+ Mr Han raises questions about the differential diagnosis of cutaneous manifestations
653
+ of sarcoidosis in tattoos. We included drug eruptions, T-cell lymphoma, and
654
+ tuberculosis as differential diagnoses for our patient with tattoo sarcoidosis.
655
+ One of the most common differential diagnoses is foreign body granuloma. These
656
+ reactions are attributable to the pigment in tattoo ink. Histologically they
657
+ can be differentiated by the presence of foreign bodies. Generally, reactions
658
+ to single pigments are found in foreign body granulomas; if multiple pigments
659
+ are involved, systemic sarcoidosis is more likely.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
660
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429690\">\n<title>Incorrect
661
+ Study Name</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429690</link>\r\n<description>&lt;span
662
+ class=\"paragraphSection\"&gt;In the Review Article entitled &#8220;Stroke
663
+ Prevention in Atrial Fibrillation: A Systematic Review&#8221; in the May 19,
664
+ 2015, issue of &lt;span style=\"font-style:italic;\"&gt;JAMA&lt;/span&gt;,
665
+ the ARISTOLE trial was incorrectly expanded. It should have read &#8220;Apixaban
666
+ for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation.&#8221;
667
+ This article was corrected online.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429690</dc:identifier>\r\n<dc:publisher>American
668
+ Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
669
+ of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
670
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
671
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429690\"><b>Incorrect
672
+ Study Name</b></A><br /> <br /><i>JAMA The Journal of the American Medical
673
+ Association, Vol. , No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;In
674
+ the Review Article entitled &#8220;Stroke Prevention in Atrial Fibrillation:
675
+ A Systematic Review&#8221; in the May 19, 2015, issue of &lt;span style=\"font-style:italic;\"&gt;JAMA&lt;/span&gt;,
676
+ the ARISTOLE trial was incorrectly expanded. It should have read &#8220;Apixaban
677
+ for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation.&#8221;
678
+ This article was corrected online.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
679
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429689\">\n<title>Incorrect
680
+ Values Reported</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429689</link>\r\n<description>&lt;span
681
+ class=\"paragraphSection\"&gt;In the Original Investigation entitled &#8220;Cannabinoids
682
+ for Medical Use: A Systematic Review and Meta-analysis&#8221; published in
683
+ the June 23/30, 2015, issue of &lt;span style=\"font-style:italic;\"&gt;JAMA&lt;/span&gt;,
684
+ the value for the average reduction in the Ashworth spasticity scale should
685
+ have been reported as &#8220;weighted mean difference, &#8722;0.12 (95% CI,
686
+ &#8722;0.24 to 0.01); 5 trials.&#8221; This article was corrected online.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429689</dc:identifier>\r\n<dc:publisher>American
687
+ Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
688
+ of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
689
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
690
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429689\"><b>Incorrect
691
+ Values Reported</b></A><br /> <br /><i>JAMA The Journal of the American Medical
692
+ Association, Vol. , No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;In
693
+ the Original Investigation entitled &#8220;Cannabinoids for Medical Use: A
694
+ Systematic Review and Meta-analysis&#8221; published in the June 23/30, 2015,
695
+ issue of &lt;span style=\"font-style:italic;\"&gt;JAMA&lt;/span&gt;, the value
696
+ for the average reduction in the Ashworth spasticity scale should have been
697
+ reported as &#8220;weighted mean difference, &#8722;0.12 (95% CI, &#8722;0.24
698
+ to 0.01); 5 trials.&#8221; This article was corrected online.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
699
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429713\">\n<title>Effect
700
+ of Nutrient Supplementation on Cognitive Function</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429713</link>\r\n<description>&lt;span
701
+ class=\"paragraphSection\"&gt;This randomized trial reports that among older
702
+ individuals with age-related macular degeneration supplements containing long-chain
703
+ fatty acids and/or lutein and zeaxanthin had no effect on cognitive function.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429713</dc:identifier>\r\n<dc:creator>Chew
704
+ EY</dc:creator>\n<dc:creator>Clemons TE, Agr&amp;#243;n E, et al.</dc:creator>\n<dc:publisher>American
705
+ Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
706
+ of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
707
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
708
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429713\"><b>Effect
709
+ of Nutrient Supplementation on Cognitive Function</b></A><br />Chew EY Clemons
710
+ TE, Agr&#243;n E, et al.<br /><i>JAMA The Journal of the American Medical
711
+ Association, Vol. , No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;This
712
+ randomized trial reports that among older individuals with age-related macular
713
+ degeneration supplements containing long-chain fatty acids and/or lutein and
714
+ zeaxanthin had no effect on cognitive function.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
715
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429714\">\n<title>Time
716
+ to Epinephrine After Pediatric In-Hospital Cardiac Arrest</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429714</link>\r\n<description>&lt;span
717
+ class=\"paragraphSection\"&gt;This study uses data for pediatric patients
718
+ from the Get With the Guidelines&#8211;Resuscitation registry to report associations
719
+ between delay in epinephrine and survival and neurological outcome after pediatric
720
+ in-hospital cardiac arrest.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429714</dc:identifier>\r\n<dc:creator>Andersen
721
+ LW</dc:creator>\n<dc:creator>Berg KM</dc:creator>\n<dc:creator>Saindon BZ</dc:creator>\n<dc:creator>et
722
+ al.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
723
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
724
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
725
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429714\"><b>Time
726
+ to Epinephrine After Pediatric In-Hospital Cardiac Arrest</b></A><br />Andersen
727
+ LW Berg KM, Saindon BZ, et al.<br /><i>JAMA The Journal of the American
728
+ Medical Association, Vol. , No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;This
729
+ study uses data for pediatric patients from the Get With the Guidelines&#8211;Resuscitation
730
+ registry to report associations between delay in epinephrine and survival
731
+ and neurological outcome after pediatric in-hospital cardiac arrest.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
732
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429715\">\n<title>Mutation
733
+ Clearance After Chemotherapy and Outcomes in AML</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429715</link>\r\n<description>&lt;span
734
+ class=\"paragraphSection\"&gt;This cohort study investigates clearance patterns
735
+ of somatic mutations in acute myeloid leukemia patients given induction chemotherapy,
736
+ and associations between those patterns and clinical outcomes.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429715</dc:identifier>\r\n<dc:creator>Klco
737
+ JM</dc:creator>\n<dc:creator>Miller CA</dc:creator>\n<dc:creator>Griffith
738
+ M</dc:creator>\n<dc:creator>et al.</dc:creator>\n<dc:publisher>American Medical
739
+ Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal of the
740
+ American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
741
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
742
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429715\"><b>Mutation
743
+ Clearance After Chemotherapy and Outcomes in AML</b></A><br />Klco JM Miller
744
+ CA, Griffith M, et al.<br /><i>JAMA The Journal of the American Medical
745
+ Association, Vol. , No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;This
746
+ cohort study investigates clearance patterns of somatic mutations in acute
747
+ myeloid leukemia patients given induction chemotherapy, and associations between
748
+ those patterns and clinical outcomes.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
749
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429696\">\n<title>Engaging
750
+ Primary Care Clinicians in Early Obesity Prevention Research</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429696</link>\r\n<description>&lt;span
751
+ class=\"paragraphSection\"&gt;This commentary describes a report published
752
+ in &lt;span style=\"font-style:italic;\"&gt;JAMA Pediatrics&lt;/span&gt; summarizing
753
+ a National Institutes of Health workshop about primary care clinician involvement
754
+ in preventing early childhood obesity.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429696</dc:identifier>\r\n<dc:creator>Faith
755
+ MS</dc:creator>\n<dc:creator>Stettler N</dc:creator>\n<dc:creator>Pietrobelli
756
+ A.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
757
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
758
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
759
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429696\"><b>Engaging
760
+ Primary Care Clinicians in Early Obesity Prevention Research</b></A><br />Faith
761
+ MS Stettler N, Pietrobelli A.<br /><i>JAMA The Journal of the American Medical
762
+ Association, Vol. , No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;This
763
+ commentary describes a report published in &lt;span style=\"font-style:italic;\"&gt;JAMA
764
+ Pediatrics&lt;/span&gt; summarizing a National Institutes of Health workshop
765
+ about primary care clinician involvement in preventing early childhood obesity.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
766
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429697\">\n<title>Prostate
767
+ Cancer Screening</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429697</link>\r\n<description>&lt;span
768
+ class=\"paragraphSection\"&gt;This JAMA Clinical Guidelines Synopsis summarizes
769
+ the US Preventive Services Task Force&#8217;s (2012) and American Urological
770
+ Association&#8217;s (2013) clinical practice guidelines for prostate cancer
771
+ screening.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429697</dc:identifier>\r\n<dc:creator>Eggener
772
+ SE</dc:creator>\n<dc:creator>Cifu AS</dc:creator>\n<dc:creator>Nabhan C.</dc:creator>\n<dc:publisher>American
773
+ Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
774
+ of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
775
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
776
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429697\"><b>Prostate
777
+ Cancer Screening</b></A><br />Eggener SE Cifu AS, Nabhan C.<br /><i>JAMA
778
+ The Journal of the American Medical Association, Vol. , No. (2015) pp. -
779
+ </i><br />&lt;span class=\"paragraphSection\"&gt;This JAMA Clinical Guidelines
780
+ Synopsis summarizes the US Preventive Services Task Force&#8217;s (2012) and
781
+ American Urological Association&#8217;s (2013) clinical practice guidelines
782
+ for prostate cancer screening.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
783
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429692\">\n<title>Clinical
784
+ Significance of Positive Antinuclear Antibody Test</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429692</link>\r\n<description>&lt;span
785
+ class=\"paragraphSection\"&gt;A 30-year-old woman with polyarthralgias responsive
786
+ to celecoxib has an ANA titer of 1:80. How do you interpret this test result&#39;&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429692</dc:identifier>\r\n<dc:creator>Fatemi
787
+ G</dc:creator>\n<dc:creator>Kermani TA.</dc:creator>\n<dc:publisher>American
788
+ Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
789
+ of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
790
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
791
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429692\"><b>Clinical
792
+ Significance of Positive Antinuclear Antibody Test</b></A><br />Fatemi G Kermani
793
+ TA.<br /><i>JAMA The Journal of the American Medical Association, Vol. , No.
794
+ \ (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;A 30-year-old
795
+ woman with polyarthralgias responsive to celecoxib has an ANA titer of 1:80.
796
+ How do you interpret this test result&#39;&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
797
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429703\">\n<title>Military
798
+ Misconduct and Homelessness Among US Veterans, 2001-2012</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429703</link>\r\n<description>&lt;span
799
+ class=\"paragraphSection\"&gt;This study used Veterans Health Administration
800
+ data to investigate the association between misconduct-related separations
801
+ and homelessness among recently returned active-duty US military service members.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429703</dc:identifier>\r\n<dc:creator>Gundlapalli
802
+ AV</dc:creator>\n<dc:creator>Fargo JD</dc:creator>\n<dc:creator>Metraux S</dc:creator>\n<dc:creator>et
803
+ al.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
804
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
805
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
806
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429703\"><b>Military
807
+ Misconduct and Homelessness Among US Veterans, 2001-2012</b></A><br />Gundlapalli
808
+ AV Fargo JD, Metraux S, et al.<br /><i>JAMA The Journal of the American
809
+ Medical Association, Vol. , No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;This
810
+ study used Veterans Health Administration data to investigate the association
811
+ between misconduct-related separations and homelessness among recently returned
812
+ active-duty US military service members.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
813
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429704\">\n<title>Opioid
814
+ Dependence Treatment in the Emergency Department</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429704</link>\r\n<description>&lt;span
815
+ class=\"paragraphSection\"&gt;&lt;strong&gt;To the Editor&lt;/strong&gt; In
816
+ the article about emergency department (ED)&#8211;initiated buprenorphine/naloxone
817
+ treatment for opioid dependence, Dr D&#8217;Onofrio and colleagues omitted
818
+ important information and then focused on the most optimistic outcomes to
819
+ infer a benefit.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429704</dc:identifier>\r\n<dc:creator>Swartz
820
+ AW.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
821
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
822
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
823
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429704\"><b>Opioid
824
+ Dependence Treatment in the Emergency Department</b></A><br />Swartz AW. <br
825
+ /><i>JAMA The Journal of the American Medical Association, Vol. , No. (2015)
826
+ pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;&lt;strong&gt;To the
827
+ Editor&lt;/strong&gt; In the article about emergency department (ED)&#8211;initiated
828
+ buprenorphine/naloxone treatment for opioid dependence, Dr D&#8217;Onofrio
829
+ and colleagues omitted important information and then focused on the most
830
+ optimistic outcomes to infer a benefit.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
831
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429701\">\n<title>Highlights
832
+ for August 25, 2015</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429701</link>\r\n<description>&lt;br&gt;\nArticle
833
+ URL: http://jama.jamanetwork.com/article.aspx?articleID=2429701&lt;br&gt;\nCitation:
834
+ \ (2015) &lt;br&gt;\nPublication Date: Tue, 25 Aug 2015 00:00:00 GMT&lt;br&gt;\nJournal:
835
+ JAMA The Journal of the American Medical Association</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429701</dc:identifier>\r\n<dc:publisher>American
836
+ Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
837
+ of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
838
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
839
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429701\"><b>Highlights
840
+ for August 25, 2015</b></A><br /> <br /><i>JAMA The Journal of the American
841
+ Medical Association, Vol. , No. (2015) pp. - </i><br />\nArticle URL: http://jama.jamanetwork.com/article.aspx?articleID=2429701\nCitation:
842
+ \ (2015) \nPublication Date: Tue, 25 Aug 2015 00:00:00 GMT\nJournal: JAMA
843
+ The Journal of the American Medical Association</p>]]></content:encoded>\r\n</item>\n<item
844
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2338495\">\n<title>Sexual
845
+ Health in America</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2338495</link>\r\n<description>&lt;span
846
+ class=\"paragraphSection\"&gt;This Viewpoint discusses a framework for improving
847
+ patient care and public sexual health.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2338495</dc:identifier>\r\n<dc:creator>Satcher
848
+ D</dc:creator>\n<dc:creator>Hook EW</dc:creator>\n<dc:creator>III</dc:creator>\n<dc:creator>Coleman
849
+ E.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
850
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
851
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
852
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2338495\"><b>Sexual
853
+ Health in America</b></A><br />Satcher D Hook EW, III, Coleman E.<br /><i>JAMA
854
+ The Journal of the American Medical Association, Vol. , No. (2015) pp. -
855
+ </i><br />&lt;span class=\"paragraphSection\"&gt;This Viewpoint discusses
856
+ a framework for improving patient care and public sexual health.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
857
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429723\">\n<title>Fusing
858
+ Randomized Trials With Big Data</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429723</link>\r\n<description>&lt;span
859
+ class=\"paragraphSection\"&gt;This Viewpoint proposes ways that electronic
860
+ health records and other &#8220;big data&#8221; can be integrated with randomized
861
+ trial designs to leverage the strengths of both for research inferences.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429723</dc:identifier>\r\n<dc:creator>Angus
862
+ DC.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
863
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
864
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
865
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429723\"><b>Fusing
866
+ Randomized Trials With Big Data</b></A><br />Angus DC. <br /><i>JAMA The Journal
867
+ of the American Medical Association, Vol. , No. (2015) pp. - </i><br />&lt;span
868
+ class=\"paragraphSection\"&gt;This Viewpoint proposes ways that electronic
869
+ health records and other &#8220;big data&#8221; can be integrated with randomized
870
+ trial designs to leverage the strengths of both for research inferences.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
871
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2319350\">\n<title>Quality
872
+ Metrics for Physical and Behavioral Health Care Integration</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2319350</link>\r\n<description>&lt;span
873
+ class=\"paragraphSection\"&gt;This Viewpoint discusses developing quality
874
+ metrics in behavioral and general health care to encourage more cost-effective
875
+ care and improve the status quo.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2319350</dc:identifier>\r\n<dc:creator>Goldman
876
+ ML</dc:creator>\n<dc:creator>Spaeth-;Rublee B</dc:creator>\n<dc:creator>Pincus
877
+ H.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
878
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
879
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
880
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2319350\"><b>Quality
881
+ Metrics for Physical and Behavioral Health Care Integration</b></A><br />Goldman
882
+ ML Spaeth-Rublee B, Pincus H.<br /><i>JAMA The Journal of the American Medical
883
+ Association, Vol. , No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;This
884
+ Viewpoint discusses developing quality metrics in behavioral and general health
885
+ care to encourage more cost-effective care and improve the status quo.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
886
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2338303\">\n<title>Middle
887
+ East Respiratory Syndrome: A Global Health Challenge</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2338303</link>\r\n<description>&lt;span
888
+ class=\"paragraphSection\"&gt;This Viewpoint discusses the importance of a
889
+ well-trained and well-prepared health workforce in controlling outbreaks such
890
+ as Middle East respiratory syndrome.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2338303</dc:identifier>\r\n<dc:creator>Gostin
891
+ LO</dc:creator>\n<dc:creator>Lucey D.</dc:creator>\n<dc:publisher>American
892
+ Medical Association</dc:publisher>\n<prism:PublicationName>JAMA The Journal
893
+ of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
894
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
895
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2338303\"><b>Middle
896
+ East Respiratory Syndrome: A Global Health Challenge</b></A><br />Gostin LO
897
+ Lucey D.<br /><i>JAMA The Journal of the American Medical Association, Vol.
898
+ , No. (2015) pp. - </i><br />&lt;span class=\"paragraphSection\"&gt;This
899
+ Viewpoint discusses the importance of a well-trained and well-prepared health
900
+ workforce in controlling outbreaks such as Middle East respiratory syndrome.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n<item
901
+ rdf:about=\"http://jama.jamanetwork.com/article.aspx?articleID=2429718\">\n<title>The
902
+ &#8220;Good Person&#8221; Sign</title>\r\n<link>http://jama.jamanetwork.com/article.aspx?articleID=2429718</link>\r\n<description>&lt;span
903
+ class=\"paragraphSection\"&gt;When I started medical school, I received a
904
+ lot of (mostly unsolicited) advice on various topics, ranging from specialty
905
+ choice to the importance of keeping work-life balance to how to befriend nurses
906
+ in order to get things done. I would listen passively while friends and family
907
+ blathered on about how comfortable their subspecialists&#8217; lifestyles
908
+ were. One recurring theme that I actively paid attention to was how often
909
+ people advised me to avoid becoming &#8220;one of those&#8221; doctors who
910
+ distanced themselves from their patients. I didn&#8217;t quite understand
911
+ why some people could ever view physicians to be uncaring, cold, and callous,
912
+ and why physicians allowed themselves to be perceived as such. Medicine is
913
+ still the noblest of professions, and one would expect altruism as a baseline
914
+ for all who go into the field. Personally, I was able to hold on tightly to
915
+ my humanity and positive attitude throughout the preclinical years of medical
916
+ school without issue. I even received high marks for compassion and empathy
917
+ in our &#8220;doctoring&#8221; courses. At that point in my training I continued
918
+ to feel as though I were above falling victim to the fate of the heartless
919
+ physician. So why, I wondered in my short, unwrinkled, and as yet unblemished
920
+ white coat, were some physicians so detached from their patients&#39; Once
921
+ the clinical years started, I quickly discovered the answer.&lt;/span&gt;</description>\r\n<dc:identifier>http://jama.jamanetwork.com/article.aspx?articleID=2429718</dc:identifier>\r\n<dc:creator>Dempsey
922
+ TM.</dc:creator>\n<dc:publisher>American Medical Association</dc:publisher>\n<prism:PublicationName>JAMA
923
+ The Journal of the American Medical Association</prism:PublicationName>\n<prism:publicationDate>Tue,
924
+ 25 Aug 2015 00:00:00 GMT</prism:publicationDate>\n<content:encoded><![CDATA[<p><a
925
+ href=\"http://jama.jamanetwork.com/article.aspx?articleID=2429718\"><b>The
926
+ &#8220;Good Person&#8221; Sign</b></A><br />Dempsey TM. <br /><i>JAMA The
927
+ Journal of the American Medical Association, Vol. , No. (2015) pp. - </i><br
928
+ />&lt;span class=\"paragraphSection\"&gt;When I started medical school, I
929
+ received a lot of (mostly unsolicited) advice on various topics, ranging from
930
+ specialty choice to the importance of keeping work-life balance to how to
931
+ befriend nurses in order to get things done. I would listen passively while
932
+ friends and family blathered on about how comfortable their subspecialists&#8217;
933
+ lifestyles were. One recurring theme that I actively paid attention to was
934
+ how often people advised me to avoid becoming &#8220;one of those&#8221; doctors
935
+ who distanced themselves from their patients. I didn&#8217;t quite understand
936
+ why some people could ever view physicians to be uncaring, cold, and callous,
937
+ and why physicians allowed themselves to be perceived as such. Medicine is
938
+ still the noblest of professions, and one would expect altruism as a baseline
939
+ for all who go into the field. Personally, I was able to hold on tightly to
940
+ my humanity and positive attitude throughout the preclinical years of medical
941
+ school without issue. I even received high marks for compassion and empathy
942
+ in our &#8220;doctoring&#8221; courses. At that point in my training I continued
943
+ to feel as though I were above falling victim to the fate of the heartless
944
+ physician. So why, I wondered in my short, unwrinkled, and as yet unblemished
945
+ white coat, were some physicians so detached from their patients&#39; Once
946
+ the clinical years started, I quickly discovered the answer.&lt;/span&gt;</p>]]></content:encoded>\r\n</item>\n\r\n\t\r\n
947
+ \ <rdf:Description rdf:ID=\"manifest\">\r\n <mn:channels>\r\n <rdf:Seq>\r\n
948
+ \ <rdf:li rdf:resource=\"http://www.journaltocs.hw.ac.uk/api/journals\"
949
+ />\r\n </rdf:Seq>\r\n </mn:channels>\r\n </rdf:Description>\r\n\r\n</rdf:RDF>"
950
+ http_version:
951
+ recorded_at: Thu, 03 Sep 2015 20:09:20 GMT
952
+ recorded_with: VCR 2.9.3